# Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom

> **NCT07690215** · — · NOT_YET_RECRUITING · sponsor: **AbbVie** · enrollment: 200 (estimated)

## Conditions studied

- Migraine

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07690215
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07690215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07690215, "Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07690215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*